S3: Drug Dependence and Tolerance Flashcards

1
Q

What is substance abuse?

A

Substance abuse is where a person consumes a drug in ways that are harmful to themselves or others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List characteristics of drug addiction. How is drug addiction clinically defined?

A

It is a chronic relapsing disorder:
- Compulsion to seek and take drug.
- Loss of control in limiting intake.
- Emergence of a negative emotion state (dysphoria, anxiety, irritability).
Clinically: A maladaptive pattern of substance use leading to clinically significant impairment or distress as manifested by two (or more) of the following occurring with a 12 month period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What book do psychiatrists used to diagnose addiction?

A

DSM-5 book.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List some factors that make an individual vulnerable to develop addiction

A
  • Enviroment (stress is a big trigger).
  • Drug induced effect causes neurochemical changes in the brain which can make individuals much more vulnerable to develop addiction.
  • Genetic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe how a mental health disorder can have co-morbilities with drug addiction

A

Drug abuse/dependence is found often with other conditions such as: Depression, anxiety, schizophrenia, PTSD.

  • People abuse drugs because they may be addicted.
  • Emotional disorder is a key predictor of alcohol use.
  • Social anxiety disorders is severe in 60% of drug abusers seeking help.
  • Metal health co-morbidity with drug addiction is accompanied by more sever systems, longer illness duration, higher service utilisation and higher relapse rate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the difference between psychological addiction and physical addiction?

A

“Psychological addiction” = Drugs of abuse activate same brain systems as natural rewards and so are rewarding (make you feel good).
“Physical addiction” = To self-medicate withdrawal symptoms (e.g. dysphoria, cramping), common with heroin and alcohol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the stages of drug addiction?

A
  1. Starts with peer pressure/ first time taking the drug. Peer pressure can reinforce and drive someone into taking a drug.
  2. Euphoric effect can be reached which encourages someone to continue
  3. Usually the cycle ends here (e.g. For individuals who smoke on nights out). However, some people develop tolerance where they need a larger quantity of drug to reach euphoric effect that they are seeking.
  4. Some people who develop tolerance then develop dependence.
    - Initially, early in the addiction cycle it is the pleasure and the euphoric effect that drives the individual into taking the drug.
    - At the later stage when you become dependent, it is the ‘self medication’ to get rid of the withdrawal symptoms that drives them to continue taking the drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is drug tolerance?

A

When a person’s reaction to a drug decreases such that larger doses are needed achieve the same effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is drug dependence?

A

Drug dependence is an adaptive state that develops from repeated drug administration, and which results in emergence of physical and emotional withdrawal symptoms upon cessation of drug use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the symptoms of abstinence syndrome (LC) from drug dependence

A
  • Physical: Sweating, gooseflesh (cold turkey), irritability, aggression
  • The physical withdrawal symptoms are usually short-lived.
  • Psychological, craving to avoid withdraw effects. They also suffer from emotional withdrawal symptoms such as extreme anxiety, depression, irritability, aggression and these withdrawal symptoms are long-lived and can last up to a year. These are motivational triggers to relapse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name and explain important areas in the brain involved in drug dependence

A
  • Orbital frontal cortex –> motivational drive is what gives value to the reward.
  • Nucleus accumbens and ventral pallidum –> reward centres of the brain and the reason we feel pleasure and these are activated in drug addiction.
  • Amygdala and hippocampus –> learning and memory (and emotional learning) which is important in drug addiction.
  • Prefrontal cortex and anterior cingulate cortex which are the executive centres in our brain which help us make judgements and decision’s. These are hugely affected in those who are suffering from drug addiction so their decisions may be impaired.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe how drugs ‘hijack’ the dopamine reward system

A
  • Dopamine is a reward transmitter in nucleus accumbens. Drugs ‘hijack’ this system and stimulate this reward pathway at a higher level (compared to natural reward levels). This is positive reinforcement at encourages an individual to keep taking the drug to feel the euphoric effects.
  • This can lead to dependence. The reward centres of the brain become supressed and not as much dopamine is released and everyday pleasures e.g. Food and sex will not activate these reward pathways. The drug will help stimulate the dopaminergic neurones to release dopamine and activate the reward pathway so the individual will seek the drug to feel the pleasurable effects again.
  • This explains why sufferers may suffer from dopamine and low mood (emotional withdrawal symptoms) due to low dopamine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List different acute targets (receptors) for different drugs

A
  • Opiods: agonist at MOP, DOP, KOP receptors.
  • Cocaine: Dopamine transporter blocker involved in reuptake of dopamine (so cocaine is an indirect DA agonist).
  • Amphetamine: Dopamine release by displacing dopamine from their vesicles (indirect DA agonist).
  • Alcohol: Facilitates GABA A inhibitory receptor and inhibits NMDA receptor function.
  • Nicotine: Agonist at nACh receptors.
  • Cannabinoids: Agonist at CB1 receptors.
  • Phencyclidine: NMDA receptor antagonist.
  • Hallucinogens: 5-HT 2A agonist.
  • All these drugs activate the reward pathway, inducing the release of dopamine from NAcc. However, they do this from different mechanisms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe Psychostimulant: Amphetamine

A
  • Amphetamine like drugs like methylphenidate and MDMA release cytosolic monoamines.
  • Amphetamines increases dopamine. It gets into the cell bouten via the dopamine transporter and displaces dopamine from synaptic vesicles, this is called “reverse transport”. The dopamine just then floats out through the transporter.
  • Because amphetamines can get into the cells, it makes prolonged use neurotoxic. It causes degeneration of amine containing nerve terminals and cell death.
  • Therapeutic uses include ADHD, appetite suppressants and narcolepsy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List pharmalogical effects of amphetamines

A
  • Increased alertness and locomotor stimulation (increased agression).
  • Euphoria/Excitement.
  • Stereotypes behaviour.
  • Anorexia.
  • Decreased physical and mental fatigue (improves monotonous tasks).
  • Peripheral sympathomimetic actions (increase blood pressure and decrease gastric motility).
  • Confidence improves/lack of tiredness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe Central Stimulant: Cocaine

A
  • Cocaine will block re-uptake of dopamine/catecholamine at synapses so you get more dopamine in the synapses.
  • Cocaine also blocks NA and serotonin transporters so increases their levels as well.
17
Q

List pharmalogical effects of cocaine

A
  • Euphoria
  • Locomotor stimulation - fewer stereotyped behaviours than amphetamine.
  • Heightened pleasure - lower tendency for delusions, hallucinations and paranoia.
18
Q

Describe psychomimetic: MDMA (ecstasy)

A
  • It inhibits monoamine transporters (mainly 5-HT). It also releases 5-HT so there is a large 5-HT increase (followed by depletion).
  • Increase of 5-HT linked to psychotomimetics effects.
  • Increased DA linked to euphoria (followed by rebound dysphoria).
19
Q

Describe Opioids: Heroin

A
  • Opioids produce intense euphoria via acting on MOP. Diamorphine (heroin) high abuse potential.
  • Tolerance is seen within 12-24 hours.
20
Q

Describe General Depressants: Alcohol

A
  • Potentiates GABA-mediated inhibition.
  • Inhibits presynaptic Ca2+ entry though voltage gated Ca2+ channels so it inhibits transmitter release,
  • Disinhibits mesolimbic DAergic neurones (increases reward)
    Induces the release of endogenous opioid peptides which has a reward effect decrease by naltrexone (endogenous opioid involvement).
21
Q

List pharmacological effects of alcohol

A
  • Slurred speech, motor in-coordination, increased self confidence, euphoria.
  • Impaired cognitive and motor performance.
  • Higher levels linked to labile mood: euphoria and melancholy, aggression and submission.
22
Q

List pharmacological effects of nicotine

A
  • nACh receptors, a4β2 subtype. Receptors are ligand-gated cation channels (pre- and post-synaptic).
  • Enhance transmitter release and neuronal excitability including opioid peptides.
  • Cortex and hippocampus (cognitive function) and ventral tegmental area (DA release and reward).
  • Increased alertness and decrease irritability (dependent on dose and situation).
23
Q

Describe the acute effect of drug abuse on the hypothalamic-adrenal axis (HPA)

A
  • HPA is stimulated by stress and releases cortisol.
  • All drugs are known to affect this HPA axis leading to lack of stress coping.
  • Opioids inhibit HPA axis humans.
  • Cocaine activates HPA axis.
24
Q

Describe drug tolerance at molecular level with opioid as an example

A
  • Opioids bind at opioid receptor.
  • Release of dopamine activating the pleasure response and pain relief.
  • Opioid receptor is saturated with too much opioid use.
  • Homeostasis occurs and opioid receptor becomes desensitised (via kinases phosphorylating and proteins binding).
  • So now there is still binding of receptor and no signalling so this is tolerance.
  • This is however, reversible.
25
Q

Describe withdrawal syndrome for different drugs

A
  • Psychostimulants: Deep sleep, lethargy, depression, anxiety and hunger.
  • MDMA (ecstasy): Depression, anxiety, irritability, increased aggression.
  • Heroin: Sweating, gooseflesh (cold turkey), irritability, aggression.
  • Nicotine: Irritability, hunger, weight gain, impaired cognitive and motor performance, craving (persisting many years).
  • Alcohol: Tremor, nausea, sweating fever, hallucinations, seizures, confusion, agitation, aggression.
26
Q

What are the chronic effects of drugs (negative reinforcement)?

A
  • Suppression of reward pathways.
  • Recruitment of stress pathway (HPA).
  • Hypofunction of FCx (executive areas of brain).
27
Q

Mechanism of dependence

A
  • Upregulation of a4B2 for dopamine.
  • Downregulation of a4B2 receptors in those with substance addiction.
  • Dopamine and dopamine receptor are both suppressed which is highly correlated with craving for the drug in an attempt to activate the reward pathway.
  • Rapid development of tolerance (desensitisation of nACh receptors)
28
Q

Describe the brain pathway changes during drug addictiong

A
  • Connections from these centres are much stronger in drug dependent individual.
  • The executive centres of brain are hypoactive (PFC and ACG) so inhibitory centres from PFC and ACG to OFC (motivational drive) are supressed.
  • This means the inhibitory stopping of taking the drug is suppressed so many say that taking the drug is automatic in addiction as lack of control over OFC.
29
Q

How do you treat substance abuse?

A
  • Treatment of substance abuse is mainly psychological (via CBT/groups).
  • The other treatment is pharmacotherapy.
30
Q

List substances for which pharmacotherapy is available

A

Opioids, Alcohol, Benzodiazepines and Tobacco (nicotine dependence).

31
Q

List substances for which pharmacotherapy is not available

A

Cocaine, Methamphetamine, Hallucinogens, Cannabis and Solvents/inhalants.

32
Q

Describe dependence treatment for opioids

A
  • Lofexidine (non substitute method of detoxification) which is a central a2-agonist. Suppresses some components of withdrawal syndrome.
  • Methadone (substitution method of detoxification) is a long acting drug, no euphoria to morphine.
    These are both opioids.
  • Naltrexone, opioid antagonist prevents euphoria to opioids (stops noradrenergic release). It is given daily to addicts to prevent lapses.
  • Buprenorphine (partial agonist, substitution method of detoxification).
33
Q

Describe dependence treatment for alcohol

A
  • Benzodiazepines (e.g. diazepam) effective against seizures.
  • Clonidine, ⍺2-adrenoceptor agonist (inhibits excessive transmitter release).
  • Propranolol, β-blocker (blocks excessive sympathetic activity).
  • Acamprosate, weak NMDA antagonist (interferes with synaptic plasticity).
  • Disulfiram, (inhibits acetaldehyde dehydrogenase) causes accumulation of acetaldehyde making alcohol consumption unpleasant (Asian flush syndrome - early hangover).
  • Naltrexone, opioid antagonist (blocks opioid receptor) reduces alcohol-induced reward.
34
Q

Describe dependence treatment for nicotine

A
  • Nicotine replacement therapy (NRT). This relieves sychological and physiological withdrawal syndrome, reduces cigarette consumption but not nicotine abstinence and can be given as patch,
    spray, e-cigarettes etc.
  • Bupropion. This is developed as antidepressant (blocks monoamine reuptake) and nicotinic antagonist. It may increase ­ [DA] in nucleus accumbens and can induce seizures, eating disorders and mania (bipolar disorder).
  • Varenicline (Champix) which is a partial a4b2 nAChR agonist (both nicotinic receptor), full agonist for a7 nACHR.
    It is more effective than NRT.